Walking, vigorous physical activity, and markers of hemostasis and inflammation in healthy men and women

Scandinavian Journal of Medicine and Science in Sports

Volumn 18, Issue 6, 2008, Pages 736-741

  Hamer, M ^a   Steptoe, A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular risk; Exercise; Hemostasis; Inflammation; Walking

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; HEMOSTASIS; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; WALKING;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEMOSTASIS; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; MOTOR ACTIVITY; WALKING;

EID: 56849091253     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2007.00747.x     Document Type: Article

References (37)

1. Asikainen TM, Miilunpalo S, Kukkonen-Harjula K, Nenonen A, Pasanen M, Rinne M, Uusi-Rasi K, Oja P, Vuori I. Walking trials in postmenopausal women: effect of low doses of exercise and exercise fractionization on coronary risk factors. Scand J Med Sci Sports 2003 : 13 : 284 292.
2. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, Guralnik JM, Ferrucci L. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004 : 59 : 242 248.
3. Chief Medical Officer. At least five a week: evidence on the impact of physical activity and its relationship to health, Department of Health, London, UK., 2004.
4. Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005 : 46 : 667 675.
5. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001 : 86 : 3257 3265.
6. Danesh J, et al. (Fibrinogen Studies Collaboration). Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality. An individual participant meta-analysis. JAMA 2005 : 294 : 1799 1809.
7. Davey SG, Shipley MJ, Batty GD, Morris JN, Marmot M. Physical activity and cause-specific mortality in the Whitehall study. Public Health 2000 : 114 : 308 315.
8. Duncan GE, Anton SD, Sydeman SJ, Newton Jr. RL, Corsica JA, Durning PE, Ketterson TU, Martin AD, Limacher MC, Perri MG. Prescribing exercise at varied levels of intensity and frequency: a randomized trial. Arch Intern Med 2005 : 165 : 2362 2369.
9. Duncan GE, Perri MG, Anton SD, Limacher MC, Martin AD, Lowenthal DT, Arning E, Bottiglieri T, Stacpoole PW. Effects of exercise on emerging and traditional cardiovascular risk factors. Prev Med 2004 : 39 : 894 902.
10. Elosua R, Molina L, Fito M, Arquer A, Sanchez-Quesada JL, Covas MI, Ordonez-Llanos J, Marrugat J. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 2003 : 167 : 327 334.
11. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 2002 : 13 : 561 568.
12. Gaffney PJ, Wong MY. Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thromb Haemost 1992 : 68 : 428 432.
13. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006 : 83 : 461S 465S.
14. Hamer M. The relative influences of fitness and fatness on inflammatory factors. Prev Med 2007 : 44 : 3 11.
15. Huffman KM, Samsa GP, Slentz CA, Duscha BD, Johnson JL, Bales CW, Tanner CJ, Houmard JA, Kraus WE. Response of high-sensitivity C-reactive protein to exercise training in an at-risk population. Am Heart J 2006 : 152 : 793 800.
16. Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, Suzuki E, Shimano H, Yamamoto S, Kondo K, Ohashi Y, Yamada N, Sone H. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med 2007 : 167 : 999 1008.
17. Lee KW, Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003 : 163 : 2368 2392.
18. Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Speizer FE, Hennekens CH. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 1999 : 341 : 650 658.
19. Marcell TJ, McAuley KA, Traustadottir T, Reaven PD. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism 2005 : 54 : 533 541.
20. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, White I, Brunner E, Feeney A. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991 : 337 : 1387 1393.
21. McDermott MM, Ferrucci L, Liu K, Criqui MH, Greenland P, Green D, Guralnik JM, Ridker PM, Taylor LM, Rifai N, Tian L, Zheng J, Pearce WH, Schneider JR, Vonesh E. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2005 : 53 : 1688 1696.
22. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events - potential mediating mechanisms. Circulation 2007 : 116 : 2110 2118.
23. Mora S, Lee IM, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 2006 : 295 : 1412 1419.
24. Morris JN, Hardman AE. Walking to health. Sports Med 1997 : 23 : 306 332.
25. Murphy MH, Murtagh EM, Boreham CA, Hare LG, Nevill AM. The effect of a worksite based walking programme on cardiovascular risk in previously sedentary civil servants [NCT00284479]. BMC Public Health 2006 : 6 : 136.
26. Murphy MH, Nevill AM, Murtagh EM, Holder RL. The effect of walking on fitness, fatness and resting blood pressure: a meta-analysis of randomised, controlled trials. Prev Med 2007 : 44 : 377 385.
27. Rennie KL, McCarthy N, Yazdgerdi S, Marmot M, Brunner E. Association of the metabolic syndrome with both vigorous and moderate physical activity. Int J Epidemiol 2003 : 32 : 600 606.
28. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 : 340 : 115 126.
29. Singh-Manoux A, Hillsdon M, Brunner E, Marmot M. Effects of physical activity on cognitive functioning in middle age: evidence from the Whitehall II prospective cohort study. Am J Public Health 2005 : 95 : 2252 2258.
30. Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol: Endocrinol Metab 2003 : 285 : E433 E437.
31. Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, McFarlin BK, Timmerman KL, Coen PM, Felker J, Talbert E. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4. Brain Behav Immun 2005 : 19 : 389 397.
32. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA 2002 : 288 : 1994 2000.
33. Tsubono Y, Tsuji I, Fujita K, Nakaya N, Hozawa A, Ohkubo T, Kuwahara A, Watanabe Y, Ogawa K, Nishino Y, Hisamichi S. Validation of walking questionnaire for population-based prospective studies in Japan: comparison with pedometer. J Epidemiol 2002 : 12 : 305 309.
34. Tully MA, Cupples ME, Chan WS, McGlade K, Young IS. Brisk walking, fitness, and cardiovascular risk: a randomized controlled trial in primary care. Prev Med 2005 : 41 : 622 628.
35. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002 : 105 : 1785 1790.
36. Ware JE. Measuring patient's views: the optimum outcome measure. SF36: a valid, reliable assessment of health from the patient's point of view. BMJ 1993 : 306 : 1429 1440.
37. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002 : 23 : 1764 1770.